Previous studies have demonstrated that at the membrane protein level, IDH-wildtype GBM has a higher PD-L1 positive expression rate than that of IDH-mutant GBM (90.1% versus 9.1%, respectively) [31]. The gene discussed is CD274; the disease is glioblastoma.